Back to top
more

Merit Medical Systems (MMSI)

(Delayed Data from NSDQ)

$88.74 USD

88.74
1,093,175

+4.62 (5.49%)

Updated Aug 2, 2024 04:00 PM ET

After-Market: $88.71 -0.03 (-0.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 15% (214 out of 251)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

PDCO or MMSI: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

PDCO vs. MMSI: Which Stock Is the Better Value Option?

Merit Medical (MMSI) Q4 Earnings & Revenues Beat Estimates

by Zacks Equity Research

Merit Medical's (MMSI) fourth-quarter results gain from higher revenues and solid segmental performance benefit. However, contraction in gross margin remains a concern.

Merit Medical (MMSI) Tops Q4 Earnings and Revenue Estimates

by Zacks Equity Research

Merit Medical (MMSI) delivered earnings and revenue surprises of 17.65% and 2.24%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Merit Medical (MMSI) Q3 Earnings & Revenues Miss Estimates

by Zacks Equity Research

Merit Medical's (MMSI) Q3 earnings gain from higher revenues and solid segmental performance benefit. However, contraction in gross margin remains a concern.

Merit Medical (MMSI) Q3 Earnings and Revenues Lag Estimates

by Zacks Equity Research

Merit Medical (MMSI) delivered earnings and revenue surprises of -37.78% and -1.65%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Merit Medical (MMSI) Q3 Earnings Expected to Decline

by Zacks Equity Research

Merit Medical (MMSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Merit Medical (MMSI) Down 37.6% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

Merit Medical (MMSI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Merit Medical (MMSI) Q2 Earnings & Revenues Miss Estimates

by Zacks Equity Research

Higher revenues and solid segmental performance margins benefit Merit Medical's (MMSI) Q2 earnings. However, contraction in both gross and operating margins remains a concern.

Merit Medical (MMSI) Q2 Earnings and Revenues Miss Estimates

by Zacks Equity Research

Merit Medical (MMSI) delivered earnings and revenue surprises of -16.00% and -1.28%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Merit Medical (MMSI) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

Merit Medical (MMSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Will Pharmacy International Hit Walgreens (WBA) Q3 Earnings?

by Zacks Equity Research

Challenging market conditions, especially in retail, causes a slowdown in the Retail Pharmacy International division at Walgreens Boots (WBA).

HSIC vs. MMSI: Which Stock Is the Better Value Option?

by Zacks Equity Research

HSIC vs. MMSI: Which Stock Is the Better Value Option?

Merit Medical Acquires Brightwater Medical for $35 Million

by Zacks Equity Research

The Brightwater Medical-acquisition broadens Merit Medical's (MMSI) product offerings.

Merit Medical Systems Sees Hammer Chart Pattern: Time to Buy?

by Zacks Equity Research

Merit Medical Systems has been struggling lately, but the selling pressure may be coming to an end soon.

Here's Why You Should Bet on Merit Medical (MMSI) Stock Now

by Zacks Equity Research

Merit Medical (MMSI) continues to benefit from solid product pipeline, HeRO product line and persistent focus on R&D.

Merit Medical (MMSI) Down 4.4% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

Merit Medical (MMSI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Sweta Killa headshot

Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?

by Sweta Killa

Sector ETF report for PSCH

Here is Why Growth Investors Should Buy Merit Medical (MMSI) Now

by Zacks Equity Research

Merit Medical (MMSI) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Merit Medical (MMSI) Q1 Earnings & Revenues Beat Estimates

by Zacks Equity Research

Higher revenues, solid segmental performance and strong adjusted gross margins benefit Merit Medical's (MMSI) Q1 earnings. However, higher expenses remain a concern.

XRAY or MMSI: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

XRAY vs. MMSI: Which Stock Is the Better Value Option?

Merit Medical (MMSI) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

Merit Medical (MMSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Merit Medical (MMSI) Up 5.5% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Merit Medical (MMSI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Merit Medical (MMSI) Q4 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Merit Medical (MMSI) delivered earnings and revenue surprises of 6.67% and 1.36%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Here's Why Investors Should Bet on Merit Medical (MMSI) Now

by Zacks Equity Research

Merit Medical's (MMSI) upbeat guidance for 2019 is indicative of the company's brighter prospects.

    Top Ranked Growth Stocks to Buy for March 7th

    by Zacks Equity Research

    Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, March 7th